Search alternatives:
marker decrease » larger decrease (Expand Search), marked increase (Expand Search), markedly decreased (Expand Search)
marked decrease » marked increase (Expand Search)
ct marked » _ marked (Expand Search), a marked (Expand Search), n marked (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
marker decrease » larger decrease (Expand Search), marked increase (Expand Search), markedly decreased (Expand Search)
marked decrease » marked increase (Expand Search)
ct marked » _ marked (Expand Search), a marked (Expand Search), n marked (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
<b>Warming alters plankton body-size distributions in a large field experiment</b>
Published 2024“…We found a nonlinear decrease in the overall mean body size of zooplankton with warming, with a 57% reduction at +8°C. …”
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx
Published 2025“…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …”
-
16
Table 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx
Published 2025“…</p>Methods<p>We retrospectively analyzed clinical data from 200 DLBCL patients and 185 healthy controls, focusing on lipid and lipoprotein levels, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), and apolipoprotein E (ApoE). …”
-
17
-
18
Data Sheet 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx
Published 2025“…</p>Methods<p>We retrospectively analyzed clinical data from 200 DLBCL patients and 185 healthy controls, focusing on lipid and lipoprotein levels, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), and apolipoprotein E (ApoE). …”
-
19
-
20